Fourth Annual Chicago Supportive Oncology Conference

Treatment of colorectal cancer since the introduction of irinotecan

Heinz-Josef Lenz, MD

Keck School of Medcine, USC/Norris Comprehensive Cancer Center, Los Angeles, CA

Irinotecan-based chemotherapy regimens increasingly offer the possibility of effective palliation that crosses seemlessly into chronic survivability.

Commun Oncol 2007;4(suppl 2):3–4   print e-mail full text 63 kb